Precautions when using entrectinib

Entrectinib (Entrectinib) is a targeted therapy drug used to treat ALK (tyrosine kinase), ROS1< span> (ROS1tyrosine kinase) fusion-positive non-small cell lung cancer (NSCLC) and locally advanced or metastatic solid tumors. The following are the precautions for taking entrectinib:

1.Check before taking medication:

Before starting entrectinib, doctors usually conduct a comprehensive evaluation, including the patient's medical history, genetic mutations, clinical symptoms, and other potential health problems. In addition, a series of tests, such as blood tests, electrocardiogram (ECG), and liver function tests, may be needed to ensure that the patient is suitable for treatment with this drug.

2.Dose and regimen:

The dosage and regimen of entrectinib are usually determined by the doctor based on the patient's specific condition and severity of illness. Patients should strictly follow the doctor's prescription, take the medication exactly as directed, and do not adjust the dosage or change the medication regimen on their own.

3.Medication time:

Enrectinib is usually taken by mouth once daily. Patients should try to take the medication at the same time every day, and can choose to take it before or after meals. The medication time can be determined according to personal habits and doctor's recommendations.

4.Dietary restrictions:

While taking entrectinib, patients should avoid consuming citrus fruits (such as grapefruit) and citrus juice at the same time, as these foods may affect the absorption and metabolism of the drug and increase the risk of adverse reactions.

5.Drug interactions:

Patients should avoid concurrent use of entrectinib with other drugs while taking entrectinib unless specifically directed by their physician. Certain drugs may interact with entrectinib, affecting its efficacy or increasing the risk of adverse reactions. Before starting treatment with entrectinib, patients should tell their doctor about all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements.

6.Adverse reaction monitoring:

While taking entrectinib, patients should closely monitor their physical condition and pay attention to the emergence of any adverse reactions. Common adverse reactions include fatigue, nausea, vomiting, diarrhea, headache, loss of appetite, rash, etc. If serious adverse reactions or prolonged discomfort occur, patients should report it to their doctor immediately.

7.Liver function monitoring:

Entrectinib may affect liver function, so patients need to have regular liver function tests while taking the drug. Patients should report to their doctor immediately if they develop jaundice, upper abdominal discomfort, loss of appetite, fatigue and other symptoms that may be related to abnormal liver function.

8.Electrocardiogram monitoring:

Because entrectinib may cause QT interval prolongation and increase the risk of cardiac arrhythmias, patients generally require ECG monitoring before starting the drug and during treatment.

9.Pregnant and breastfeeding women:

Entrectinib may cause harm to the fetus, so pregnant and lactating women should avoid becoming pregnant while using the drug and take effective contraceptive measures while using the drug. If the patient is pregnant or plans to become pregnant, the doctor should be informed immediately.

10.Follow the doctor’s advice:

Patients should closely follow the doctor's advice and guidance while using entrectinib, such as regular follow-up visits, compliance with medication time, and attention to adverse reactions. If there are any questions or uncertainties, patients should consult their doctor promptly.

In general, entrectinib is an effective targeted therapy, but during use, patients need to strictly abide by the doctor's prescriptions and recommendations, regularly monitor their physical condition, and report any adverse reactions in a timely manner to ensure the best therapeutic effect and safety.